Pueraria mirifica is a Thai plant root, sold as a supplement, that acts as a strong plant estrogen; midlife women use it for menopausal changes. Small Thai studies show healthier vaginal tissue after menopause; hot-flash relief looked similar to prescription estrogen, but those trials lacked an inactive placebo. Main concerns are irregular bleeding and breast symptoms, mostly in younger users, and open questions about long-term breast and uterine safety. (Full Review)
| Marker | Target | Why |
|---|---|---|
| ALT and AST | ALT about 7–35 U/L; AST about 10–35 U/L | Safety check: rising values stop use |
| Hemoglobin | 12.0–15.5 g/dL in women | Safety check: anemia was reported |
| Endometrial thickness | No established target; track change from own baseline | Safety check: thickening or bleeding stops use |
| QTc interval | Below about 460 ms in women | Safety check: prolongation stops use |
| LDL, HDL and triglycerides | No established target; track change from own baseline | Expected to change: mixed lipid effects reported |
| C-reactive protein (high-sensitivity) | No established target; track change from own baseline | Expected to change: a doubling was reported in trials |
| Vaginal maturation index | No established target; track change from own baseline | Expected to change: rises with estrogen-like effect on vaginal tissue |
Cadence: Baseline, then 4 weeks, 3 months and 6 months, then every 6–12 months during continued use; liver enzymes and blood counts at 3 and 6 months, lipids at 3 months, ultrasound at 6 months or immediately with any bleeding, ECG 2–4 weeks after starting in at-risk people